Apogenix develops innovative immuno-oncology therapeutics for the treatment of cancer and other malignant diseases. Based on a proprietary technology platform, the company has built a promising pipeline of drug candidates that target different tumor necrosis factor (TNF) superfamily-dependent signaling pathways, thereby triggering an anti-tumor immune response.

Apogenix maintains excellent relationships with renowned academic institutions conducting research in the fields of cancer and malignant diseases and is part of an extensive international scientific and medical network.

The work environment at Apogenix is characterized by an open, communicative atmosphere with numerous opportunities for personal growth and development. Employees benefit from a high level of independence and responsibility, as well as performance-based salaries.

Phone: +49 6221 58608-0
E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.